Subscribe To
Sanofi in $1 billion deal to buy u.s.-based amunix pharma
Drugmaker Sanofi SA will buy Amunix pharmaceuticals Inc for an upfront payment of about $1 billion, mar...
December 21, 2021, 1:12 am
Sanofi in $1 billion deal to buy u.s.-based amunix pharma
Drugmaker Sanofi SA will buy Amunix pharmaceuticals Inc for an upfront payment of about $1 billion, mar...
December 21, 2021, 1:12 am
Pharma could be fabulous in 2022
pharmaceuticals stocks and the related exchange traded funds are turning solid performances in 2021. In...
December 20, 2021, 1:35 pm
Pharma could be fabulous in 2022
pharmaceuticals stocks and the related exchange traded funds are turning solid performances in 2021. In...
December 20, 2021, 1:35 pm
Pharma could be fabulous in 2022
pharmaceuticals stocks and the related exchange traded funds are turning solid performances in 2021. In...
December 20, 2021, 1:35 pm
Xeris biopharma: market is snubbing the strongbridge acquisition
Xeris pharmaceuticals acquired Strongbridge Biopharma in a stock swap and contingent value rights trans...
December 19, 2021, 7:52 pm
Xeris biopharma: market is snubbing the strongbridge acquisition
Xeris pharmaceuticals acquired Strongbridge Biopharma in a stock swap and contingent value rights trans...
December 19, 2021, 7:52 pm
Xeris biopharma: market is snubbing the strongbridge acquisition
Xeris pharmaceuticals acquired Strongbridge Biopharma in a stock swap and contingent value rights trans...
December 19, 2021, 7:52 pm
Takeda pharmaceutical: underappreciated potential
ENTYVIO's sales totaled about ¥130.5 billion in Q2 2021, up 4.1% quarter-on-quarter and 23.5% Q1 2020. Revenue for the company's key 14 medicines inc...
December 19, 2021, 10:46 am
Takeda pharmaceutical: underappreciated potential
ENTYVIO's sales totaled about ¥130.5 billion in Q2 2021, up 4.1% quarter-on-quarter and 23.5% Q1 2020. Revenue for the company's key 14 medicines inc...
December 19, 2021, 10:46 am
Takeda pharmaceutical: underappreciated potential
ENTYVIO's sales totaled about ¥130.5 billion in Q2 2021, up 4.1% quarter-on-quarter and 23.5% Q1 2020. Revenue for the company's key 14 medicines inc...
December 19, 2021, 10:46 am
Moderna drops covid-19 vaccine patent application, cooling legal fight with government
The pharmaceutical giant says government scientists shouldn't be credited on a patent for a key ingredi...
December 17, 2021, 7:53 pm
Moderna drops covid-19 vaccine patent application, cooling legal fight with government
The pharmaceutical giant says government scientists shouldn't be credited on a patent for a key ingredi...
December 17, 2021, 7:53 pm
Moderna drops covid-19 vaccine patent application, cooling legal fight with government
The pharmaceutical giant says government scientists shouldn't be credited on a patent for a key ingredi...
December 17, 2021, 7:53 pm
Big pharma innovation outlook looks healthy
pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They hav...
December 17, 2021, 1:20 pm
Big pharma innovation outlook looks healthy
pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They hav...
December 17, 2021, 1:20 pm
Big pharma innovation outlook looks healthy
pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They hav...
December 17, 2021, 1:20 pm
Mindmed advances phase 2a lsd microdose trial for adult adhd
Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) a...
December 17, 2021, 1:16 pm
Mindmed advances phase 2a lsd microdose trial for adult adhd
Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) a...
December 17, 2021, 1:16 pm
Mindmed advances phase 2a lsd microdose trial for adult adhd
Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) a...
December 17, 2021, 1:16 pm